Journal of Current Research in Scientific Medicine

ORIGINAL ARTICLE
Year
: 2017  |  Volume : 3  |  Issue : 2  |  Page : 88--93

Antimicrobial activity of Vitamin C demonstrated on uropathogenic Escherichia coli and Klebsiella pneumoniae


Rohan Jacob Verghese1, Stephen K Mathew2, Alice David3 
1 Medical Student, Pondicherry Institute of Medical Sciences, Kalapet, Puducherry, India
2 Department of Microbiology, Believers Church Medical College, Thiruvalla, Kerala, India
3 Research Associate, Believers Church Medical College, Thiruvalla, Kerala, India

Correspondence Address:
Dr. Stephen K Mathew
Department of Microbiology, Believers Church Medical College, Kuttapuzha P.O., Thiruvalla - 689 103, Kerala
India

Purpose: Studies have demonstrated the ability of Vitamin C (ascorbic acid) to inhibit pathogenic bacteria and inhibit biofilms. The effect of varying concentrations of ascorbic acid on bacterial growth was studied on uropathogenic Escherichia coli and Klebsiella pneumoniae. The concentration at which maximal inhibition occurred was determined. Methods: All uropathogenic strains of E. coli and K. pneumoniae isolated from patients over a 3-month period were incubated in varying concentrations (5, 10 and 20 mg/ml) of Vitamin C-supplemented Trypticase Soy Broth. Effect on bacterial growth was quantified as a change in absorbance measured by spectrophotometry (450 nm), as compared to controls. Independent samples t-test was used to calculate P value. Results: Bacterial growth was inhibited at all Vitamin C concentrations. Mean absorbances of E. coli and K. pneumoniae broths containing 5, 10, and 20 mg/ml Vitamin C were significantly less than absorbances of growth control broths without Vitamin C (P < 0.005). This inhibition was independent of antimicrobial resistance profiles of isolates. Differences between mean absorbance at 10 and 20 mg/ml Vitamin C for both species were not significant (P > 0.005). Thus, the inhibitory activity of Vitamin C appears to be dose-dependent, with 10 mg/ml being the optimum concentration of ascorbic acid. Conclusions: Ascorbic acid's ability to inhibit bacterial growth may find novel clinical applications. Vitamin C may find potential use in topical antibacterial applications, or urinary bladder irrigation fluid for catheterized patients with urinary tract infections or during bladder instrumentation. There is a need to further explore the possibility of using Vitamin C safely as an effective antimicrobial agent.


How to cite this article:
Verghese RJ, Mathew SK, David A. Antimicrobial activity of Vitamin C demonstrated on uropathogenic Escherichia coli and Klebsiella pneumoniae.J Curr Res Sci Med 2017;3:88-93


How to cite this URL:
Verghese RJ, Mathew SK, David A. Antimicrobial activity of Vitamin C demonstrated on uropathogenic Escherichia coli and Klebsiella pneumoniae. J Curr Res Sci Med [serial online] 2017 [cited 2019 May 24 ];3:88-93
Available from: http://www.jcrsmed.org/article.asp?issn=2455-3069;year=2017;volume=3;issue=2;spage=88;epage=93;aulast=Verghese;type=0